MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹549 Cr | ₹405 Cr | ₹422 Cr | ₹270 Cr | ₹221 Cr |
What is the latest Total Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹549 Cr |
Mar2024 | ₹405 Cr |
Mar2023 | ₹422 Cr |
Mar2022 | ₹270 Cr |
Mar2021 | ₹221 Cr |
How is Total Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹549 Cr | 35.50 | |
Mar2024 | ₹405 Cr | -4.02 | |
Mar2023 | ₹422 Cr | 56.03 | |
Mar2022 | ₹270 Cr | 22.36 | |
Mar2021 | ₹221 Cr | - |
Compare Total Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANGALAM GLOBAL ENTERPRISE | ₹520.4 Cr | 1.4% | -4.8% | NA | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,146.8 Cr | 1.4% | -1% | -30.8% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,007.6 Cr | -3.1% | 4.8% | 7.2% | Stock Analytics | |
VENKYS (INDIA) | ₹2,135.2 Cr | -3.5% | -2% | -41.1% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,413.7 Cr | -6% | 0.3% | -29.4% | Stock Analytics | |
INDO US BIOTECH | ₹295.9 Cr | 0.2% | -18.8% | -48.2% | Stock Analytics |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANGALAM GLOBAL ENTERPRISE | 1.4% |
-4.8% |
|
SENSEX | 1.2% |
0.7% |
-1.5% |
You may also like the below Video Courses